AU6136694A - Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same - Google Patents

Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same

Info

Publication number
AU6136694A
AU6136694A AU61366/94A AU6136694A AU6136694A AU 6136694 A AU6136694 A AU 6136694A AU 61366/94 A AU61366/94 A AU 61366/94A AU 6136694 A AU6136694 A AU 6136694A AU 6136694 A AU6136694 A AU 6136694A
Authority
AU
Australia
Prior art keywords
eliciting
methods
same
neutralizing anti
broadly neutralizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61366/94A
Inventor
Albert T. Profy
Ian A Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repligen Corp
Scripps Research Institute
Original Assignee
Repligen Corp
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp, Scripps Research Institute filed Critical Repligen Corp
Publication of AU6136694A publication Critical patent/AU6136694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU61366/94A 1993-02-12 1994-02-09 Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same Abandoned AU6136694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1748593A 1993-02-12 1993-02-12
US017485 1993-02-12
PCT/US1994/001458 WO1994018232A1 (en) 1993-02-12 1994-02-09 Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same

Publications (1)

Publication Number Publication Date
AU6136694A true AU6136694A (en) 1994-08-29

Family

ID=21782852

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61366/94A Abandoned AU6136694A (en) 1993-02-12 1994-02-09 Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same

Country Status (2)

Country Link
AU (1) AU6136694A (en)
WO (1) WO1994018232A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP660698A0 (en) 1998-10-21 1998-11-12 University Of Queensland, The A method of protein engineering
AUPR030900A0 (en) 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
US20100143442A1 (en) 2003-02-05 2010-06-10 Queensland University Of Technology Growth factor complexes and modulation of cell migration and growth
US7960513B2 (en) 2004-12-17 2011-06-14 Monash University Antibody against a human ADAM protease
RU2012127364A (en) 2009-11-30 2014-01-10 Квинсленд Юниверсити Оф Текнолоджи CHIMERS FIBRONECTIN: GROWTH FACTOR
WO2018237357A1 (en) 2017-06-22 2018-12-27 University Of Maryland, Baltimore Broadly neutralizing antibodies against hiv
WO2019173801A1 (en) * 2018-03-09 2019-09-12 Atreca, Inc. Nucleic acids encoding anti-hiv antibodies
EP3762033A4 (en) * 2018-03-09 2021-12-08 Atreca, Inc. Anti-hiv antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91843A0 (en) * 1988-10-03 1990-06-10 Repligen Corp Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids

Also Published As

Publication number Publication date
WO1994018232A1 (en) 1994-08-18

Similar Documents

Publication Publication Date Title
AU709406C (en) Combined vaccines comprising hepatitis B surface antigen and other antigens
AU1209495A (en) Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
AU6095696A (en) Immunogenic peptides of prostate specific antigen
AU640774B2 (en) Hair-treating microemulsion composition and method of preparing and using the same
AU7977291A (en) Single use dispensing sachets and method of and means for manufacture of same
AU3107289A (en) Chimeric antibodies directed against human carcinoembryonic antigen
AU7757591A (en) Device for forming slits and method of forming the same
AU1866895A (en) Human monoclonal antibodies to herpes simplex virus and methods therefor
AU5641798A (en) Artificial antibodies, method of producing the same and use thereof
AU2391195A (en) Lymphocyte activation antigens and antibodies thereto
AU8955691A (en) Structural member and method of manufacture
AU5064990A (en) Improved strapping joint and method for forming same
AU6136694A (en) Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
AU2493184A (en) Specific cea-family antigens, antibodies specific thereto and their methods of use
AU550364B2 (en) Immunogen of lidocaine-protein conjugate and antibodies derived therefrom
AU1538392A (en) Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations
AU6220096A (en) Method for the simultaneous detection of different antibodies and/or antigens
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
AU2158292A (en) Cea-binding proteins and methods for their isolation and use
AU4274293A (en) Human monoclonal antibodies against cytomegalovirus and method for preparation thereof
AU2696495A (en) Method for determining hiv-1 antigen and antibody
AU6496094A (en) Tumor-associated antigens recognized by t cells and the uses of these antigens
AU2498288A (en) Hybridoma and method of generating same
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
AU5561094A (en) Method of producing antibodies with conjugates of b-cell-antigen and denatured carrier